Lumen Bioscience today announced positive results from the RePreve Clinical Trial of oral LMN-201, an investigational biologic cocktail drug, that demonstrate a statistically significant global cure ...

"This is the year for landscapers to focus on efficiencies, productivity, and profitability using modern-day technologies with industry best practices," said Bradley. "LMN offers the largest ...

SEATTLE, April 3, 2025 /PRNewswire/ -- In a landmark achievement for its pioneering spirulina-based drug development platform, Lumen announced today top-line results from the sentinel cohort of its ...

The London, Ontario-based company is an industry leader with a proven track record of delivering exceptional online courses for landscape owners. Its team joins LMN immediately, filling an increasing ...